Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

MSCV-human CSF-1Rwt-IRES-GFP Citations (1)

Originally described in: Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ Nature. 1987 Feb 5-11;325(6104):549-52.
PubMed Journal

Articles Citing MSCV-human CSF-1Rwt-IRES-GFP

Articles
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease. Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS. Am J Hematol. 2022 Mar 1;97(3):293-302. doi: 10.1002/ajh.26441. Epub 2022 Jan 3. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.